Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate

Cancer Research

Volumn 60, Issue 3, 2000, Pages 525-529

  Henderson, Barbara W ^a   Busch, Theresa M ^a,b   Vaughan, Lurine A ^a   Frawley, Noreen P ^a   Babich, Debra ^a   Sosa, Tara A ^a   Zollo, Joseph D ^a   Dee, Anthony S ^a   Cooper, Michele T ^a   Bellnier, David A ^a   Greco, William R ^a   Oseroff, Allan R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN; SINGLET OXYGEN;

ARTICLE; BASAL CELL CARCINOMA; CANCER INHIBITION; CELL METABOLISM; CLINICAL ARTICLE; HUMAN; OXYGENATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; TEMPERATURE;

ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; DIHEMATOPORPHYRIN ETHER; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; OXYGEN;

EID: 17444436438     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy. J Natl. Cancer Inst., 90: 889-905, 1998.
2. Foster, T. H., and Gao, L. Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density. Radiat. Res., 130: 379-383, 1992.
3. Foster, T. H., Murant, R. S., Bryant, R. G., Knox, R. S., Gibson, S. L., and Hilf, R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res., 126: 296-303, 1991.
4. Tromberg, B. J., Orenstein, A., Kimel, S., Barker, S. J., Hyatt, J., Nelson, J. S., and Berns, M. W. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol., 52: 375-385, 1990.
5. Sitnik, T., and Henderson, B. W. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem. Photobiol., 67: 462-466, 1998.
6. Sitnik, T. M., Hampton, J. A., and Henderson, B. W. Reduction of tumor oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br. J. Cancer. 77: 1386-1394, 1998.
7. Henderson, B. W., and Fingar, V. H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res., 47: 3110-3114, 1987.
8. Höckel, M., Schäffer, U., Lambert, A., Schlenger, K., Weikel, W., and Vaupel, P. The clinical relevance of tumor oxygenation in advanced cancer of the uterine cervix. In: P. W. Vaupel, D. K. Kelleher, and M. Günderoth (eds.). Tumor Oxygenation, pp. 243-248. New York: G. Fischer, 1995.
9. Brizel, D. M., Rosner, G. L., Harrelson, J., Prosnitz, L. R., and Dewhirst, M. W. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys., 30: 635-642, 1994.
10. 2 tension measurements. Cancer Res., 51: 3316-3322, 1991.
11. Bellnier, D. A., Greco, W. R., Parsons, J. C., Oseroff, A. R., Kuebler, A., and Dougherty, T. J. An assay for the quantitation of Photofrin® in tissues and fluids. Photochem. Photobiol., 66: 237-244, 1997.
12. Henning, J. P., Fournier, R. L., and Hampton, J. A. A transient mathematical model of oxygen depletion during photodynamic therapy. Radiat. Res., 142: 221-226, 1995.
13. Buscaglia, D. A., Shanler, S. D., Mang, T. S., Wilson, B. D., Jones, C., Stoll, H. L., Dougherty, T. J., and Oseroff, A. R. Photodynamic therapy with Photofrin II successfully treats basal cell carcinomas in patients with basal cell nevus syndrome. J. Investig. Dermatol., 102: 615, 1994.
14. Fingar, V. H., Wieman, J., Wiehle, S. A., and Cerrilo, P. B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res., 53: 4914-4921, 1992.
15. Georgakoudi, I., Nichols, M. G., and Foster, T. H. The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem. Photobiol., 65: 135-144, 1997.
16. Dougherty, T. J., Gomer, C. J., and Weishaupt, K. R. Energetics and efficiency of photoinactivation of murine tumor cells containing hematoporphyrin. Cancer Res., 36: 2330-2333, 1976.
17. Cornell, R. C., Greenway, H. T., Tucker, S. B., Edwards, L., Ashworth, S., Vance, J. C., Tanner, D. J., Taylor, E. L., Smiles, K. A., and Peets, E. A. Intralesional interferon therapy for basal cell carcinoma. J. Am. Acad. Dermatol., 23: 694-700, 1990.
18. Korbelik, M., Krosl, G., Krosl, J., and Dougherty, G. J. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res, 56: 5647-5652, 1996.
19. Curry, P. M., and Levy, J. G. Tumor inhibitory lymphocytes derived from the lymph nodes of mice treated with photodynamic therapy. Photochem. Photohiol, 6IS: 72S, 1995.
20. Boyle, D. G., and Potter, W. R. Photobleaching of Photofrin II as a means of eliminating skin photosensitivity. Photochem. Pholobiol., 46: 997-1001, 1987.